首页> 外国专利> Pharmacological components of oral management include immediate release of 5-AzaCitidin without cosmetic coating; and treatment of diseases associated with abnormal cell proliferation, such as cell cancer, acute poliomyelitis and pus cancer. No, No.

Pharmacological components of oral management include immediate release of 5-AzaCitidin without cosmetic coating; and treatment of diseases associated with abnormal cell proliferation, such as cell cancer, acute poliomyelitis and pus cancer. No, No.

机译：口服药物的药理成分包括5-AzaCitidin的立即释放而无需化妆品包衣;和与细胞异常增殖有关的疾病的治疗，例如细胞癌，急性脊髓灰质炎和脓癌。不，不。

页面导航

摘要
著录项
相似文献

摘要

Pharmaceutical composition comprising 5 - azacytidine,In the composition released 5-azacytidine substantially in the stomach after being administered to a patient by oral Route; and use for the treatment of a disease associated with ProliferationRation of abnormal cells.

机译：包含5-氮杂胞苷的药物组合物，所述组合物在通过口服途径给予患者后基本上在胃中释放5-氮杂胞苷;并用于治疗与异常细胞增殖相关的疾病。

著录项

公开/公告号CL2009001170A1

专利类型
公开/公告日2010-06-04

原文格式PDF
申请/专利权人 CELGENE CORPORATION;
展开▼

申请/专利号CL20090001170
发明设计人 JEFFREY B. ETTER MEI LAI JAY THOMAS BACKSTROM;
展开▼

申请日2009-05-14
分类号A61K31/706;A61K31/7068;A61K9/20;A61K9/28;A61P35/00;A61P35/02;
国家 CL
入库时间 2022-08-21 18:47:16

相似文献

专利
外文文献
中文文献